Johnson & Johnson vs Zimmer Biomet Holdings, Inc.
JNJ vs ZBH — side-by-side comparison from reported financials. JNJ leads 6, ZBH leads 5 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Zimmer Biomet Holdings, Inc.
ZBH · Healthcare
$89.00+0.14%Mixed
| Metric | JNJ | ZBH |
|---|---|---|
| Price | $261.79 | $89.00 |
| Market cap | $631B | $17.0B |
| Revenue (TTM) | $97.9B | $8.51B |
| Revenue growth | +5.6% | +5.8% |
| Net margin | 21.5% | 9.5% |
| Free cash flow | $22.2B | $1.52B |
| Net cash (debt) | ($27.8B) | ($6.34B) |
| 1-year price return | +37.0% | -8.6% |
| P/E | 29.9 | 21.5 |
| P/E vs own history (cheap-side %) | 16% | 96% |
| Dividend yield | 2.00% | 1.09% |
| Return on equity | 26% | 6% |
| Altman Z-score | — | 2.15 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 140,800 | 17,000 |
Full résumé-style profiles: JNJ CV · ZBH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.